Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Other financing activities (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Other financing activities for 2 consecutive years, with -$5000.0 as the latest value for Q4 2025.

  • Quarterly Other financing activities changed N/A to -$5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$401000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$401000.0 for FY2025, N/A changed from the prior year.
  • Other financing activities for Q4 2025 was -$5000.0 at Centessa Pharmaceuticals, down from $4.4 million in the prior quarter.
  • The five-year high for Other financing activities was $4.4 million in Q2 2025, with the low at -$4.8 million in Q1 2025.